Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the transcatheter aortic valve replacement market size evolved in recent years?
The market size for transcatheter aortic valve replacement has seen accelerated expansion in recent times. The market is predicted to escalate from $5.19 billion in 2024 to $5.91 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%. The upswing during the historical period can be ascribed to factors such as the escalating incidence of aortic regurgitation, growing occurrence of cardiovascular disorders, a heightened patient inclination towards minimally invasive treatments, worldwide growth of TAVR procedures, and advantageous reimbursement policies.
What are the predictions for the transcatheter aortic valve replacement market size in the coming years?
In the coming years, the market size for transcatheter aortic valve replacement is anticipated to experience swift expansion. It’s projected that by 2029, it will reach $9.97 billion with a compound annual growth rate (CAGR) of 14.0%. The predicted growth during this forecast period can be associated with the rising incidence of aortic stenosis, a growing inclination towards minimally invasive surgeries, an increase in approved applications for TAVR procedures, favourable reimbursement policies, and heightened awareness of TAVR as a possible treatment pathway. Noteworthy trends during this period include continuous advancements in device technology, escalating cases of cardiovascular diseases, global proliferation of TAVR procedures, an ageing population demographic, and increasing healthcare spending.
Get your transcatheter aortic valve replacement market report here!
What key factors are fueling the growth of the transcatheter aortic valve replacement market?
The rise in the number of aortic stenosis cases is serving as a catalyst for the progression of the transcatheter aortic valve replacement market. Transcatheter aortic valve replacement (TAVR), a less invasive substitute for surgical aortic valve replacement (SAVR), is employed to treat aortic stenosis, a medical issue involving the constricting of the aortic valve in the heart. This method assists in reestablishing blood circulation and mitigating the effects and indicators of aortic valve stenosis. For example, statistics from the American Heart Association in May 2024 stated that over 12% of elderly people in America suffer from aortic stenosis, prevalent in individuals over 65. If neglected, it can lead to heart failure and may even prove deadly. Moreover, a report from the National Institute for Health and Care Excellence (NICE) in March 2023 stated that approximately 1.5% of UK residents over 55, or roughly 300,000, suffer from severe aortic stenosis, with almost 200,000 needing treatment for symptomatic disease, adding to more than 380,000 individuals on cardiac waiting lists by March 2023. Hence, the escalating cases of aortic stenosis act as a major propellant for the transcatheter aortic valve replacement market.
How is the global transcatheter aortic valve replacement market divided into key segments?
The transcatheter aortic valve replacement market covered in this report is segmented –
1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp
Who are the key firms paving the way for growth in the transcatheter aortic valve replacement market?
Major companies operating in the transcatheter aortic valve replacement market include Abbott Laboratories Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc, Braile Biomedica, Peijia Medical Limited, Direct Flow Medical Inc., Transcatheter Technologies GmbH, Symetis SA, JenaValve Technology Inc., Micro Interventional Devices Inc., Xeltis BV, Tendyne Holdings Inc., MVRx Inc., Keystone Heart Ltd., Colibri Heart Valve LLC, HighLife SAS, Neovasc Inc., Aegis Surgical Limited, Foldax Inc., MValve Technologies Ltd., NaviGate Cardiac Structures Inc.
Which trends are expected to transform the transcatheter aortic valve replacement market?
Product advancement is a crucial developing trend in the transcatheter aortic valve replacement (TAVR) industry. Businesses in this market are prioritizing the creation of novel technologies and innovations to cement their market position. For example, in May 2024, US-based Edwards Lifesciences, a medical technology firm, introduced the Sapien 3 Ultra Resilia valve in Europe. This marked the sole transcatheter aortic valve replacement (TAVR) system incorporating the company’s Resilia tissue technology. This forward-thinking technology, which augments the valve’s durability, utilizes bovine pericardial tissue processed with anti-calcification treatments. Incorporating this calcium-resistant technology, the Resilia platform is effective in reducing structural valve deterioration, a prominent reason for re-intervention post valve-replacement.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12031
What regions are contributing significantly to the growth of the transcatheter aortic valve replacement market?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Automotive Repair and Maintenance Global Market Report 2024
Automobile Rental And Leasing Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market
Automobiles And Heavy Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
